Geode Capital Management
GRI

Geode Capital Management’s GRI Bio GRI Stock Holding History

Geode Capital Management’s Portfolio GRI Stock Details GRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$42.2K Buy
18,438
+17,610
+2,127% +$65.6K ﹤0.01% 4354
2025
Q4 		$5.72K Buy
828
+386
+87% +$16.6K ﹤0.01% 4454
2025
Q3 		$25.5K Buy
+442
New +$20.4K ﹤0.01% 4396
2025
Q1 		– Sell
-160
Closed -$63.1K – 4492
2024
Q4 		$63.1K Buy
160
+135
+540% +$46.2K ﹤0.01% 4200
2024
Q3 		$4.28K Buy
+25
New +$10.1K ﹤0.01% 4518
2024
Q1 		– Hold
0
– -$5.66K – 4620
2023
Q4 		– Hold
0
– – – 4630
2023
Q3 		– Hold
0
– – – 4590
2023
Q2 		– Hold
0
– – – 4452
2023
Q1 		– Hold
0
– – – 4776
2022
Q4 		– Hold
0
– – – 4875
2022
Q3 		– Hold
0
– – – 5008
2022
Q2 		– Hold
0
– – – 4971
2022
Q1 		– Hold
0
– – – 4846
2021
Q4 		– Hold
0
– – – 4713
2021
Q3 		– Hold
0
– – – 4503
2021
Q2 		– Hold
0
– – – 4616

Other funds holding GRI

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

Geode Capital Management's GRI Position: Q1 2026 in Review

Geode Capital Management increased its GRI Bio (GRI) stake by 2,127% in Q1 2026, buying an estimated $65.6K and bringing the position to 18,438 shares worth $42.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4354.

Geode Capital Management first reported a position in GRI in Q3 2024 and has held it in 5 quarters since. The position peaked at $63.1K in Q4 2024. 6 funds tracked by Wall St. Rank hold GRI as of Q1 2026.

  • Geode Capital Management held 18,438 shares of GRI Bio worth $42.2K as of Q1 2026.
  • Geode Capital Management bought 17,610 GRI Bio shares in Q1 2026, an estimated $65.6K.
  • GRI Bio made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #4354 holding.
  • Geode Capital Management first reported a position in GRI Bio in Q3 2024 and has held it in 5 quarters since.
  • Geode Capital Management's GRI Bio position peaked at $63.1K in Q4 2024.
  • 6 funds tracked by Wall St. Rank held GRI Bio as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.